GREAT POINT PARTNERS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$45,010,000
-11.1%
390,000
-25.0%
7.31%
+60.5%
Q3 2020$50,645,000
-8.3%
520,232
+15.6%
4.56%
+3.2%
Q2 2020$55,224,000
+40.1%
450,0000.0%4.41%
+7.2%
Q1 2020$39,407,000
+166.0%
450,000
+217.6%
4.12%
+219.1%
Q4 2019$14,814,000
+49.6%
141,683
+88.9%
1.29%
-23.6%
Q4 2017$9,901,000
+213.4%
75,000
+215.1%
1.69%
+109.6%
Q3 2016$3,159,000
-54.5%
23,800
-76.2%
0.81%
-72.3%
Q4 2015$6,944,000
-62.7%
100,000
-50.9%
2.91%
-60.4%
Q3 2015$18,621,000203,8007.36%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2021
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders